Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
3,821,734
-
Total 13F shares
-
47,959
-
Share change
-
+47,959
-
Total reported value
-
$191,956
-
Price per share
-
$4.00
-
Number of holders
-
11
-
Value change
-
+$191,956
-
Number of buys
-
11
Institutional Holders of Quantum Biopharma Ltd. - Common Stock (QNTM) as of Q3 2024
As of 30 Sep 2024,
Quantum Biopharma Ltd. - Common Stock (QNTM) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,959 shares.
The largest 10 holders included
AdvisorShares Investments LLC, Virtu Financial LLC, HRT FINANCIAL LP, GROUP ONE TRADING LLC, NATIONAL BANK OF CANADA /FI/, OSAIC HOLDINGS, INC., Federation des caisses Desjardins du Quebec, TD Waterhouse Canada Inc., Avior Wealth Management, LLC, and BANK OF AMERICA CORP /DE/.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.